Mock-up Updates Study Tags (field_study_tags) - Any - ADEQUATE BE READY NOW Blog Call-outs CLIN-Net CoMeCT COVID-19 Data Ecraid ECRAID-Base Education EPI-Net EPOXI Interview Mpox NeoDeco NOFLU Partners People PIPELINE POS-ARI-ER POS-ARI-PC POS-cUTI POS-Disease X POS-VAP Primary Care PrIMAVeRA PRUDENCE RECLAIM RECOVERY REMAP-CAP SNAP SOS Covid STRIDE-CAP Training Vaccines 14.04.2025 Marion Koopmans receives the ESCMID Award for Outstanding Contributions in the Field of Infection 7.04.2025 Clinical research on post-COVID launched The RECLAIM Trial has commenced enrolment and the first participants have begun in the study. 28.03.2025 See you at ESCMID Global 2025 Join us at Ecraid’s exhibition booth at ESCMID's congress in Vienna. We look forward to meeting new and current collaborators. 27.03.2025 ECRAID-Prime Welcomes Georgia: Latest Study Milestones & Updates The study’s newest country enrols its first patient 19.03.2025 Ecraid hosts inaugural Science Meeting: Advancing Collaborative Research in Infectious Diseases Advancing Collaborative Research in Infectious Diseases 25.02.2025 Increasing awareness of human metapneumovirus cases underscore urgency of vaccine development Our POS-ARI-PC study is contributing to Sanofi's efforts toward developing a safe and effective vaccine. Load More
14.04.2025 Marion Koopmans receives the ESCMID Award for Outstanding Contributions in the Field of Infection
7.04.2025 Clinical research on post-COVID launched The RECLAIM Trial has commenced enrolment and the first participants have begun in the study.
28.03.2025 See you at ESCMID Global 2025 Join us at Ecraid’s exhibition booth at ESCMID's congress in Vienna. We look forward to meeting new and current collaborators.
27.03.2025 ECRAID-Prime Welcomes Georgia: Latest Study Milestones & Updates The study’s newest country enrols its first patient
19.03.2025 Ecraid hosts inaugural Science Meeting: Advancing Collaborative Research in Infectious Diseases Advancing Collaborative Research in Infectious Diseases
25.02.2025 Increasing awareness of human metapneumovirus cases underscore urgency of vaccine development Our POS-ARI-PC study is contributing to Sanofi's efforts toward developing a safe and effective vaccine.
